Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benoit I Giasson

Showing results (81-90 of 174) with videos related to

Pageof 18
Sort By:
Human Molecular Genetics|October 17, 2017
Comparison of the in vivo induction and transmission of α-synuclein pathology by mutant α-synuclein fibril seeds in transgenic miceNicola J Rutherford, Jess-Karan S Dhillon, Cara J Riffe, et al.
Neuron|June 14, 2002
Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synucleinBenoit I Giasson, John E Duda, Shawn M Quinn, et al.
The Journal of Biological Chemistry|April 21, 2005
A precipitating role for truncated alpha-synuclein and the proteasome in alpha-synuclein aggregation: implications for pathogenesis of Parkinson diseaseChang-Wei Liu, Benoit I Giasson, Karen A Lewis, et al.
Journal of Neurochemistry|July 19, 2016
Proteolysis of α-synuclein fibrils in the lysosomal pathway limits induction of inclusion pathologyAmanda N Sacino, Mieu M Brooks, Paramita Chakrabarty, et al.
Biochemistry|December 18, 2002
The environmental toxin arsenite induces tau hyperphosphorylationBenoit I Giasson, Deepak M Sampathu, Christina A Wilson, et al.
The Journal of Biological Chemistry|October 18, 2018
Physiological C-terminal truncation of α-synuclein potentiates the prion-like formation of pathological inclusionsZachary A Sorrentino, Niran Vijayaraghavan, Kimberly-Marie Gorion, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 12, 2014
Brain injection of α-synuclein induces multiple proteinopathies, gliosis, and a neuronal injury markerAmanda N Sacino, Mieu Brooks, Alex B McKinney, et al.
Plos One|September 15, 2017
A novel panel of α-synuclein antibodies reveal distinctive staining profiles in synucleinopathiesJess-Karan S Dhillon, Cara Riffe, Brenda D Moore, et al.
Acta Neuropathologica Communications|August 29, 2021
Disease-, region- and cell type specific diversity of α-synuclein carboxy terminal truncations in synucleinopathiesEthan W Hass, Zachary A Sorrentino, Yuxing Xia, et al.
The Journal of Biological Chemistry|April 9, 2005
Reversible inhibition of alpha-synuclein fibrillization by dopaminochrome-mediated conformational alterationsErin H Norris, Benoit I Giasson, Roberto Hodara, et al.
Pageof 18

Showing results (81-90 of 174) with videos related to

Sort By:
Pageof 18
Human Molecular Genetics|October 17, 2017
Comparison of the in vivo induction and transmission of α-synuclein pathology by mutant α-synuclein fibril seeds in transgenic miceNicola J Rutherford, Jess-Karan S Dhillon, Cara J Riffe, et al.
Neuron|June 14, 2002
Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synucleinBenoit I Giasson, John E Duda, Shawn M Quinn, et al.
The Journal of Biological Chemistry|April 21, 2005
A precipitating role for truncated alpha-synuclein and the proteasome in alpha-synuclein aggregation: implications for pathogenesis of Parkinson diseaseChang-Wei Liu, Benoit I Giasson, Karen A Lewis, et al.
Journal of Neurochemistry|July 19, 2016
Proteolysis of α-synuclein fibrils in the lysosomal pathway limits induction of inclusion pathologyAmanda N Sacino, Mieu M Brooks, Paramita Chakrabarty, et al.
Biochemistry|December 18, 2002
The environmental toxin arsenite induces tau hyperphosphorylationBenoit I Giasson, Deepak M Sampathu, Christina A Wilson, et al.
The Journal of Biological Chemistry|October 18, 2018
Physiological C-terminal truncation of α-synuclein potentiates the prion-like formation of pathological inclusionsZachary A Sorrentino, Niran Vijayaraghavan, Kimberly-Marie Gorion, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 12, 2014
Brain injection of α-synuclein induces multiple proteinopathies, gliosis, and a neuronal injury markerAmanda N Sacino, Mieu Brooks, Alex B McKinney, et al.
Plos One|September 15, 2017
A novel panel of α-synuclein antibodies reveal distinctive staining profiles in synucleinopathiesJess-Karan S Dhillon, Cara Riffe, Brenda D Moore, et al.
Acta Neuropathologica Communications|August 29, 2021
Disease-, region- and cell type specific diversity of α-synuclein carboxy terminal truncations in synucleinopathiesEthan W Hass, Zachary A Sorrentino, Yuxing Xia, et al.
The Journal of Biological Chemistry|April 9, 2005
Reversible inhibition of alpha-synuclein fibrillization by dopaminochrome-mediated conformational alterationsErin H Norris, Benoit I Giasson, Roberto Hodara, et al.
Pageof 18